Cargando…

Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy

Accumulation of alpha-synuclein (αSyn) protein in neurons is a renowned pathological hallmark of Parkinson’s disease (PD). In addition, accumulating evidence indicates that activated inflammatory responses are involved in the pathogenesis of PD. Thus, achieving a better understanding of the interact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Thuy Thi, Kim, Yun Joong, Ma, Hyeo-il, Kim, Young Eun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Movement Disorder Society 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820875/ https://www.ncbi.nlm.nih.gov/pubmed/35124957 http://dx.doi.org/10.14802/jmd.21078

Ejemplares similares

PTEN-Induced Putative Kinase 1 Dysfunction Accelerates Synucleinopathy
por: Nguyen, Tinh Thi, et al.
Publicado: (2022)

Temporal Evolution of Inflammation and Neurodegeneration With Alpha-Synuclein Propagation in Parkinson's Disease Mouse Model
por: Lai, Thuy Thi, et al.
Publicado: (2021)

Role of NLRP3 Inflammasome in Parkinson’s Disease and Therapeutic Considerations
por: Nguyen, Linh Thi Nhat, et al.
Publicado: (2022)

Drug-induced Parkinsonism: A strong predictor of idiopathic Parkinson’s disease
por: Jeong, Sohyun, et al.
Publicado: (2021)

Utility of the Midbrain Tegmentum Diameter in the Differential Diagnosis of Progressive Supranuclear Palsy from Idiopathic Parkinson's Disease
por: Kim, Yool-Hee, et al.
Publicado: (2015)

Huntington’s Disease Presenting as Adult-Onset Parkinsonism
por: Kwak, In Hee, et al.
Publicado: (2022)

Inflammation promotes synucleinopathy propagation
por: Kim, Tae-Kyung, et al.
Publicado: (2022)

Early Impairment of Chopsticks Skills in Parkinsonism Suggests Progressive Supranuclear Palsy
por: Kim, Young Eun, et al.
Publicado: (2020)

A Validation Study of a Smartphone-Based Finger Tapping Application for Quantitative Assessment of Bradykinesia in Parkinson’s Disease
por: Lee, Chae Young, et al.
Publicado: (2016)

Trends in the Prevalence of Drug-Induced Parkinsonism in Korea
por: Byun, Ji-Hye, et al.
Publicado: (2019)

Cognitive Dysfunction in Drug-induced Parkinsonism Caused by Prokinetics and Antiemetics
por: Ahn, Hyun Jung, et al.
Publicado: (2015)

Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
por: Alecu, Irina, et al.
Publicado: (2019)

Glucocerebrosidase Involvement in Parkinson Disease and Other Synucleinopathies
por: Almeida, Maria do Rosário
Publicado: (2012)

N30 Somatosensory Evoked Potential Is Negatively Correlated with Motor Function in Parkinson’s Disease
por: Kang, Suk Yun, et al.
Publicado: (2016)

Analysis of Dosage Mutation in PARK2 among Korean Patients with Early-Onset or Familial Parkinson's Disease
por: Chu, Min Kyung, et al.
Publicado: (2014)

Linking the Endoplasmic Reticulum to Parkinson’s Disease and Alpha-Synucleinopathy
por: Colla, Emanuela
Publicado: (2019)

Erratum: Analysis of Dosage Mutation in PARK2 among Korean Patients with Early-Onset or Familial Parkinson's Disease
por: Chu, Min Kyung, et al.
Publicado: (2015)

Anxiety in synucleinopathies: neuronal circuitry, underlying pathomechanisms and current therapeutic strategies
por: Lai, Thuy Thi, et al.
Publicado: (2023)

Parkinson's disease might increase the risk of cerebral ischemic lesions
por: Song, In-Uk, et al.
Publicado: (2017)

Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
por: Menon, Sindhu, et al.
Publicado: (2022)

Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies
por: Terkelsen, Miriam Højholt, et al.
Publicado: (2022)

Patients and Their Caregivers’ Burdens for Parkinson’s Disease in Korea
por: Baik, Jong Sam, et al.
Publicado: (2017)

An Enriched Environment Ameliorates Oxidative Stress and Olfactory Dysfunction in Parkinson’s Disease with α-Synucleinopathy
por: Wi, Soohyun, et al.
Publicado: (2018)

Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease
por: Milanese, Chiara, et al.
Publicado: (2018)

Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson’s Disease
por: Miller, Sean J., et al.
Publicado: (2022)

Validation of the Korean-Version of the Nonmotor Symptoms Scale for Parkinson's Disease
por: Koh, Seong-Beom, et al.
Publicado: (2012)

Translation and Validation of the Korean Version of the 39-Item Parkinson's Disease Questionnaire
por: Kwon, Do-Young, et al.
Publicado: (2013)

Pathological looping in the synucleinopathies: investigating the link between Parkinson’s disease and Gaucher disease
por: Kinghorn, Kerri J.
Publicado: (2011)

Presynaptic Dopaminergic Degeneration in a Patient with Beta-Propeller Protein-Associated Neurodegeneration Documented by Dopamine Transporter Positron Emission Tomography Images: A Case Report
por: Kim, Min Ki, et al.
Publicado: (2017)

Gaucher Disease and the Synucleinopathies
por: Hruska, Kathleen S., et al.
Publicado: (2006)

α-Synuclein Transgenic Drosophila As a Model of Parkinson's Disease and Related Synucleinopathies
por: Mizuno, Hideya, et al.
Publicado: (2010)

Role of α- and β-Synucleins in the Axonal Pathology of Parkinson’s Disease and Related Synucleinopathies
por: Sekigawa, Akio, et al.
Publicado: (2015)

Molecular chaperones and protein folding as therapeutic targets in Parkinson’s disease and other synucleinopathies
por: Ebrahimi-Fakhari, Darius, et al.
Publicado: (2013)

Reduced Cytosolic Calcium as an Early Decisive Cellular State in Parkinson’s Disease and Synucleinopathies
por: Betzer, Cristine, et al.
Publicado: (2018)

Correlations of Neuropsychological and Metabolic Brain Changes in Parkinson's Disease and Other α-Synucleinopathies
por: Trošt, Maja, et al.
Publicado: (2019)

Synucleinopathy-associated pathogenesis in Parkinson’s disease and the potential for brain-derived neurotrophic factor
por: Miller, Kathryn M., et al.
Publicado: (2021)

Peripheral synucleinopathy in Parkinson disease with LRRK2 G2385R variants
por: Yang, Jing, et al.
Publicado: (2021)

ATPase Thorase Deficiency Causes α-Synucleinopathy and Parkinson’s Disease-like Behavior
por: Gao, Fei, et al.
Publicado: (2022)

Genetic deletion of nitric oxide synthase 2 ameliorates Parkinson’s disease pathology and neuroinflammation in a transgenic mouse model of synucleinopathy
por: Kim, Jieun, et al.
Publicado: (2023)

Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies
por: Magalhães, Pedro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nbseth50ka33jbjqvmj3m3ocfa